Back to top
more

Better trading starts here.

Brokerage Reports

Research for OMCL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

2 items in cart

View Cart/Checkout

Omnicell, Inc. [OMCL]

Reports for Purchase

Showing records 101 - 120 ( 330 total )

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 101

12/27/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 102

12/19/2022

Daily Note

Pages: 4

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 103

12/19/2022

Daily Note

Pages: 6

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 104

12/18/2022

Industry Report

Pages: 22

Healthcare IT: 2023 Outlook

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 105

12/09/2022

Daily Note

Pages: 6

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 106

12/05/2022

Daily Note

Pages: 9

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 107

12/05/2022

Daily Note

Pages: 6

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 108

12/04/2022

Company Report

Pages: 6

Bull vs. Bear Case; See 110% Upside and 13% Downside from Current Levels

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 109

11/30/2022

Daily Note

Pages: 3

Reducing Workforce by ~9%; Expect ~7.5% Positive Impact to Annual Adj. Profits

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 110

11/14/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 111

11/14/2022

Daily Note

Pages: 6

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 112

11/02/2022

Daily Note

Pages: 4

3Q Miss; FY Guidance Lowered by 8% on Revenues and 28% on Adj. EBITDA

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 113

11/02/2022

Daily Note

Pages: 13

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 114

11/02/2022

Company Report

Pages: 5

Miss + Substantial Guide Down:Valuation Implies Troughing Setup (ex. Great Recession);Remain OW

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 115

10/18/2022

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 116

10/18/2022

Daily Note

Pages: 5

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 117

10/17/2022

Daily Note

Pages: 14

Healthcare IT: 3Q22 Earnings Preview

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 118

10/11/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 119

10/05/2022

Daily Note

Pages: 7

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Omnicell, Inc.

Industry: Medical Info Systems

Record: 120

10/05/2022

Daily Note

Pages: 5

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party